Publisher
Springer Nature Switzerland
Reference48 articles.
1. Almenawer SA, Badhiwala JH, Alhazzani W, et al. Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis. Neuro-Oncology. 2015;17:868–81.
2. Appay R, Dehais C, Maurage CA, et al. CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. Neuro-Oncology. 2019;21:1519–28.
3. Banan R, Stichel D, Bleck A, et al. Infratentorial IDH-mutant astrocytoma is a distinct subtype. Acta Neuropathol. 2020;140:569–81.
4. Brat D, Aldape K, Colman H, et al. CIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol. 2020:603–8.
5. Brat D, Cahill DP, Cimino PJ, et al. Astrocytoma, IDH-mutant. In: WHO Classification of Tumours Editorial Board. World Health Organization Classification of Tumours of the Central Nervous System. fifth ed. Lyon: International Agency for Research on Cancer; 2021.